• Publications
  • Influence
Concurrent chemoradiotherapy in non-small cell lung cancer.
BACKGROUND This is an updated version of the original review published in Issue 4, 2004. The use of concurrent chemotherapy and radiotherapy in non-small cell lung cancer (NSCLC) might be seen as aExpand
  • 362
  • 20
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Guideline development processes vary substantially, and many guidelines do not meet basic quality criteria. Standards for guideline development can help organizations ensure that recommendations areExpand
  • 480
  • 17
  • PDF
Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial
Prophylactic cranial irradiation (PCI) reduces the risk of cranial metastasis in small cell lung cancer (SCLC), but the magnitude and value of this reduction, the risks of radiation morbidity andExpand
  • 317
  • 13
The Average Body Surface Area of Adult Cancer Patients in the UK: A Multicentre Retrospective Study
The majority of chemotherapy drugs are dosed based on body surface area (BSA). No standard BSA values for patients being treated in the United Kingdom are available on which to base dose and costExpand
  • 151
  • 10
  • PDF
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines.
Conflicts of interest (COIs) have been defined by the American Thoracic Society as "a divergence between an individual's private interests and his or her professional obligations such that anExpand
  • 126
  • 9
  • PDF
Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research
In patients with non-metastatic but inoperable non-small cell lung cancer that is locally too extensive for radical radiotherapy (RT), but who have good performance status, it is important toExpand
  • 205
  • 8
Interventions before consultations for helping patients address their information needs.
BACKGROUND Patients often do not get the information they require from doctors and nurses. To address this problem, interventions directed at patients to help them gather information in theirExpand
  • 184
  • 6
  • PDF
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.
PURPOSE Venous thromboembolism (VTE) is common in cancer patients. Evidence has suggested that low molecular weight heparin (LMWH) might improve survival in patients with cancer by preventing bothExpand
  • 116
  • 4
Lung cancer management in limited resource settings: guidelines for appropriate good care.
Lung cancer is a major cause of cancer death worldwide and is becoming an increasing problem in developing countries. It is important that, in countries where health care resources are limited, theseExpand
  • 36
  • 4
Pulmonary blastoma: medium-term results from a regional center.
BACKGROUND Pulmonary blastomas are rare lung tumors that morphologically resemble fetal pulmonary structure and can exist in two forms, biphasic and monophasic. We reviewed our experience over aExpand
  • 53
  • 4